Medication Adherence in Pediatric Sickle Cell Disease and Hematopoietic Stem Cell Transplantation: An Integrative Review of Literature [0.03%]
儿童镰状细胞病和造血干细胞移植的药物依从性：文献整合综述
Misty Evans,Samereh Abdoli,Micah Skeens et al.
Misty Evans et al.
BackgroundWith the emergence of haploidentical transplantation, children with sickle cell disease (SCD) are increasingly pursuing hematopoietic stem cell transplantation (HSCT) as a curative treatment approach. However, suboptimal medicatio...
The Effect of Storytelling on Anxiety Level of Children With Cancer: One-Group Pretest-Posttest Study [0.03%]
叙事对癌症儿童焦虑水平影响的前后对照研究
Merve Kurt,Tuba Arpaci
Merve Kurt
BackgroundThis one-group pretest-posttest experimental research was conducted to determine the effect of storytelling on the anxiety levels of children diagnosed with cancer.MethodChildren aged 4-10 years and their parents in the pediatric ...
Patient Utilization and Satisfaction of Supportive Skin Care Products Among Children with Cancer Receiving Mitogen-Activated Protein Kinase Pathway Inhibitors [0.03%]
儿童肿瘤患者使用促分裂原活化蛋白激酶通路抑制剂的皮肤护理产品利用及满意度分析
Ashley Meyer,Andrea Ogle,Andrew Cluster et al.
Ashley Meyer et al.
BackgroundDrugs that target the mitogen-activated protein kinase pathway have caused frequent and significant skin toxicity, which has led to increased burden on both patients and their caregivers. Routine skin care products for daily use h...
Health Care Provider-Delivered Educational Interventions in Pediatric Oncology: A Rapid Scoping Review of Content, Feasibility, Acceptability, and Effectiveness [0.03%]
儿科肿瘤学中医疗提供者实施教育干预的快速综述：内容、可行性、可接受性和有效性
Alicia Kilfoy,Rachel Hamilton,Melissa Howlett et al.
Alicia Kilfoy et al.
BackgroundChildren with cancer and their families face complex medical, emotional, and practical challenges. Education delivered by health care providers is a critical component of high-quality pediatric oncology care, yet the scope, feasib...
Feasibility and Nurse Acceptability of Dexmedetomidine Use During I-131 MIBG Therapy in Pediatric Patients With Neuroblastoma [0.03%]
儿科神经母细胞瘤患者I-131-MIBG治疗期间使用右美托咪定的可行性和护士接受度
Jennifer Spidle,Jean C Solodiuk,Megan Lurvey et al.
Jennifer Spidle et al.
BackgroundI-131 metaiodobenzylguanidine (MIBG) therapy effectively treats high-risk neuroblastoma but exposes caregivers and healthcare providers to radiation risks. Managing patient anxiety and agitation is essential for safety. Dexmedetom...
Navigating the Shadows of Stigma in Sickle Cell Disease: A Phenomenological Study [0.03%]
探索镰状细胞病患者的阴影与偏见：现象学研究
Abby O Seydel,Mary J Isaacson,Brandon M Varilek
Abby O Seydel
BackgroundThe purpose of this study was to explore the experience of stigma among young adults living with sickle cell disease (SCD) using a hermeneutic phenomenological design.MethodSeven young adults diagnosed with SCD participated in sem...
Belinda N Mandrell,Liza-Marie Johnson,Jami S Gattuso et al.
Belinda N Mandrell et al.
BackgroundPrecision-based approaches are reshaping healthcare by tailoring assessments and therapies to a patient's individual needs. To ensure nursing remains integral to this evolving landscape, active collaboration with multidisciplinary...
Janice S Withycombe,Elizabeth A Duffy
Janice S Withycombe
Teresa Herriage,Jawhar Rawwas,Adam Sterman et al.
Teresa Herriage et al.
BackgroundChildren with relapsed/refractory (R/R) neuroblastoma are at risk for poor outcomes due to resistant disease. Naxitamab is an anti-glycolipid disialoganglioside (GD2) monoclonal antibody approved by the Food and Drug Administratio...
A Rapid Review of Supportive Care Management of Treatment-Related Acute and Long-Term Cardiac Toxicities in Children with Cancer and Childhood Cancer Survivors Who Have Received Tyrosine Kinase Inhibitors (TKIs) [0.03%]
儿童肿瘤患者及接受酪氨酸激酶抑制剂治疗的成年幸存者治疗相关急性期和远期心脏毒副作用护理管理快速回顾
Beth Fisher,Mary Keller,Nancy Dias et al.
Beth Fisher et al.
BackgroundAdvances in targeted cancer therapies have transformed the management of pediatric malignancies. Tyrosine kinase inhibitors (TKIs), a specific class of targeted agents, inhibit signaling pathways essential to cancer cell survival....